Antirheumatic medication use among pregnant women with rheumatoid arthritis: a Norwegian nationwide drug utilisation study
Open Access
- 31 December 2025
- journal article
- Published by Elsevier in EULAR Rheumatology Open
- Vol. 2 (1) , 79-89
Abstract
No abstract availableKeywords
Funding Information
- Norges Forskningsråd (322176)
This publication has 40 references indexed in Scilit:
- EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 updateAnnals of the Rheumatic Diseases, 2025
- Disease-Modifying Medications in Patients with Rheumatoid Arthritis in the USA: Trends from 2016 to 2021Drugs - Real World Outcomes, 2024
- Safety of anti-TNF agents in pregnancyJournal of Allergy and Clinical Immunology, 2021
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal DiseasesArthritis & Rheumatology, 2020
- State of the art: Reproduction and pregnancy in rheumatic diseasesAutoimmunity Reviews, 2015
- Patterns of medication use during pregnancy in rheumatoid arthritisArthritis Care & Research, 2011
- Use of antirheumatic drugs in mothers and fathers before and during pregnancy—a population‐based cohort studyPharmacoepidemiology and Drug Safety, 2009
- Disease activity of rheumatoid arthritis during pregnancy: Results from a nationwide prospective studyArthritis Care & Research, 2008
- Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritisArthritis & Rheumatism, 2006
- Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled studyReproductive Toxicology, 2004